Active

Pharma Deprée

Switched

BE0692655719

Rechtspersoon Private limited company 1 establishment

Louisastraat 33, 3120 Tremelo Activiteiten van holdings

Active for

8 year, 5 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 112,495

▲ 18% vs 2024

Profit

Growing

€ 67,217

▲ 9% vs 2024

Debts

Normal

€ 683,094

▲ 93% vs 2024

Pharma Deprée from Tremelo, company number BE0692655719, closed financial year 2025 with a result of € 67,217 after tax. For that financial year Pharma Deprée recorded a gross margin of € 112,495 and equity of € 257,179. Compared with financial year 2024, the result moved from € 61,455 to € 67,217. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.

What happened at Pharma Deprée?

What happened at Pharma Deprée in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 67,217 (▲ 9% vs 2024). Source: NBB ↗
  • New establishment in Tremelo. KBO
  • Start of the company according to the CBE. KBO

In short

From € 59,666 profit in 2021 to € 67,217 profit in 2025.

Paid € 130,470 in corporate taxes since 2021.

Best year ever: 2023, with € 72,851 profit.

Paid out € 180,000 in dividends to the owners in total.

A new publication or filing at Pharma Deprée? We notify you, reason included.

Follow Pharma Deprée

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Inne Deprée
Pharma Deprée

Behind Pharma Deprée is Inne Deprée. It owns 50% of Relst Pharma and 50% of Apotrem itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Inne Deprée

Director

Also active at: APOTREM

Establishments

Establishment units

Physical locations of this company

Registered office

Louisastraat 33

3120 Tremelo

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0692.655.719
VAT number
BE 0692.655.719
Registered office
Louisastraat 33, 3120 Tremelo
Names & denominations
Pharma Deprée
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
19 March 2018
Peppol
Active · Active since 13 Jul 2025
Activities · NACE

Activiteiten van holdings

Holdings

Frequently asked questions

What is the enterprise number of Pharma Deprée?
The enterprise number of Pharma Deprée is BE0692655719.
What is the address of Pharma Deprée?
The registered office of Pharma Deprée is located at Louisastraat 33, 3120 Tremelo.
When was Pharma Deprée founded?
Pharma Deprée was founded on 19 March 2018.
What is the main activity of Pharma Deprée?
The main activity of Pharma Deprée is "Activiteiten van holdings" (NACE code 64210).
Does Pharma Deprée have a website?
No website is currently known for Pharma Deprée.
How much profit did Pharma Deprée make in 2025?
Pharma Deprée posted a profit after taxes of € 67,217 in financial year 2025.
What is the revenue of Pharma Deprée?
As a small company, Pharma Deprée is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 112,495.
Where can I find the annual accounts of Pharma Deprée?
Pharma Deprée files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of Pharma Deprée?
According to the 2025 annual accounts, the directors of Pharma Deprée are: Inne Deprée.
Who owns Pharma Deprée?
Behind Pharma Deprée is Inne Deprée. It owns 50% of Relst Pharma and 50% of Apotrem itself.